title: Serotonin syndrome due to co-administration of linezolid and venlafaxine.
authors.forename: Stephanie Lisa
authors.initials: SL
authors.lastname: Jones
authors.forename: Eugene
authors.initials: E
authors.lastname: Athan
authors.forename: Daniel
authors.initials: D
authors.lastname: O'Brien
mesh_terms: D000081:Acetamides / Q000009:adverse effects*; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects*; D003511:Cyclohexanols / Q000009:adverse effects*; D004347:Drug Interactions; D024881:Drug Resistance, Bacterial; D006622:Hip Prosthesis / Q000009:adverse effects; D006801:Humans; D000069349:Linezolid; D008297:Male; D023303:Oxazolidinones / Q000009:adverse effects*; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology; D020230:Serotonin Syndrome / Q000209:etiology* / Q000523:psychology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D003511:Cyclohexanols; D000069349:Linezolid; D023303:Oxazolidinones; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride